For Immediate Release

2019.02.22

Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: Sunao Manabe, Representative Director, President and COO
(Code no.: 4568, First Section, Tokyo Stock Exchange)
Please address inquiries to Koji Ogawa, Corporate Officer,
Vice President, Corporate Communications Department
Telephone: +81-3-6225-1126
https://www.daiichisankyo.com

Daiichi Sankyo Appoints New Group Corporate Officers

TOKYO, Japan (February 22, 2019) - Daiichi Sankyo Company, Limited today announced the appointment of new Group corporate officers effective from April 1, 2019.

1. DAIICHI SANKYO CO., LTD.

Name

Current Responsibilities

New Responsibilities

Katsumi Fujimoto

Member of the Board
Senior Executive Officer
Head of Supply Chain Div.

Member of the Board

Toshiaki Tojo

Member of the Board
Senior Executive Officer
In charge of Vaccine Business

Member of the Board
Senior Executive Officer
In charge of Vaccine Business
and Quality & Safety Management

Junichi Koga

Senior Executive Officer
Head of R&D Div.

Senior Executive Officer
Global Head of R&D

Masahiko Ohtsuki

Corporate Officer
Vice President of Business
Development & Licensing Dept.

Executive Officer
Vice President of Business
Development & Licensing Dept.

Junichi Fukute

Corporate Officer
Vice President of Supply Chain
Planning Dept., Supply Chain Div.

Executive Officer
Head of Supply Chain Div.

Takeshi Hamaura

Corporate Officer
Head of Pharmaceutical Technology Div.

Executive Officer
Head of Pharmaceutical Technology Div.

Shoji Hirashima

Corporate Officer
Vice President of Corporate
Business Management Dept.,
Corporate Strategy & Management Div.

Executive Officer
Head of Global Brand Strategy Div.

Ryoichi Watanabe

Corporate Officer

Vice President of Internal Audit Dept.

Corporate Officer
In charge of Internal Audit Dept.

Hironobu Furuta

Corporate Officer
Vice President of Human Resources
Dept., Corporate Affairs Div.

Corporate Officer

Head of Corporate Affairs Div.

Koji Ogawa

Corporate Officer
Vice President of Corporate
Communications Dept., Corporate
Strategy & Management Div.

Corporate Officer
Head of US Corporate Div.,
Daiichi Sankyo, Inc.

Seiichiro Kumakura

Vice President of Research Function,
R&D Div.

Corporate Officer
Vice President of Research Function,
R&D Div.

Takashi Fukuoka

Vice President of Venture Science
Laboratories, R&D Div.

Corporate Officer
Executive Vice President, R&D Affairs,
Daiichi Sankyo, Inc.

Hironobu Saito

Vice President of Oncology Clinical
Development Dept., Oncology Function,
R&D Div.

Corporate Officer
Vice President of Oncology Clinical
Development Dept., Oncology Function,
R&D Div.

Wataru Takasaki

Vice President of R&D Planning &
Management Dept., R&D Div.

Corporate Officer
Head of R&D Div. and Vice President
of Oncology Function

Tomoji Hashiba

Vice President of Tohoku Branch,
Sales & Marketing Div.

Corporate Officer
Vice President of Kyushu Branch,
Sales & Marketing Div.

Miyuki Arai

Vice President of Safety and Risk
Management Dept., Quality & Safety
Management Div.

Corporate Officer
Head of Quality & Safety Management
Div.

◇Glenn Gormley (current Senior Executive Officer) will continue to serve as Executive Chairman of the Board of Daiichi Sankyo, Inc.

◇Koichi Akahane, Yoshihiro Aoyagi, Yuichi Kubo and Kohei Wada (current Executive Officer) will be appointed Corporate Advisor as of April 1st, 2019.

◇Kenji Katsumi (current Corporate Officer) will be appointed the President of Daiichi Sankyo Business Associe Co., Ltd. as of April 1st, 2019.

◇Kentaro Murakawa (current Corporate Officer) will be appointed the President of Daiichi Sankyo Espha Co., Ltd. as of April 1st, 2019.

◇Hirosumi Izawa (current Corporate Officer) will be appointed the President of Daiichi Sankyo Propharma Co., Ltd. as of April 1st, 2019.

2. DAIICHI SANKYO ESPHA CO., LTD.

Name

Current Responsibilities

New Responsibilities

Kentaro Murakawa

Corporate Officer
Vice President of Sales Planning Dept.
and Senior Director of
Sales Management Group,
Sales & Marketing Div.,
DAIICHI SANKYO CO., LTD.

President

Ichiro Ishizuka

Member of the Board
Head of Sales & Marketing Div.

Executive Vice President
Head of Sales & Marketing Div.

Hiroto Yoshiwaka

President

Member of the Board

Takeshi Shinseki

Member of the Board
In charge of Corporate Strategy and
Vice President of Corporate Business
Management Dept.

Member of the Board
Head of Corporate Strategy &
Management Div.

Kosuke Natori

Vice President of Corporate Strategy Dept.

Member of the Board
Vice President of Corporate Business
Management Dept., Corporate
Strategy & Management Div.

3. DAIICHI SANKYO HEALTHCARE CO., LTD.

Name

Current Responsibilities

New Responsibilities

Yoshiki Nishii

President

Chairman

Katsuhiko Yoshida

Member of the Board
Senior Executive Officer
In charge of Corporate Administration
and Vice president of Corporate
Planning Dept.

President

Yasuhiro Kawanaka

Member of the Board
Executive Officer
Vice President of Sales Administration Div.

Member of the Board

Masatoshi Yamamoto

Corporate Officer
Vice President of Quality and Safety
Management Dept.

Member of the Board
Corporate Officer
Vice President of Quality and Safety
Management Dept.

Tomohiko Yamaguchi

Corporate Officer
Vice President of R&D Dept.

Member of the Board
Corporate Officer
Vice President of R&D Dept.

Attachments

  • Original document
  • Permalink

Disclaimer

Daiichi Sankyo Co. Ltd. published this content on 22 February 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 22 February 2019 01:24:03 UTC